Azasan and Haemoglobin decreased - a phase IV clinical study of FDA data

Summary:

Haemoglobin decreased is reported only by a few people who take Azasan.

The phase IV clinical study analyzes which people take Azasan and have Haemoglobin decreased. It is created by eHealthMe based on reports of 304 people who have side effects while taking Azasan from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Aug, 17, 2022

304 people reported to have side effects when taking Azasan.
Among them, 3 people (0.99%) have Haemoglobin decreased.


What is Azasan?

Azasan has active ingredients of azathioprine. eHealthMe is studying from 333 Azasan users for its effectiveness, alternative drugs and more.

What is Haemoglobin decreased?

Haemoglobin decreased is found to be associated with 2,958 drugs and 2,990 conditions by eHealthMe.

Number of Azasan and Haemoglobin decreased reports submitted per year:

Could Azasan cause Haemoglobin decreased?

Gender of people who have Haemoglobin decreased when taking Azasan *:

  • female: 33.33 %
  • male: 66.67 %

Age of people who have Haemoglobin decreased when taking Azasan *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 33.33 %
  • 50-59: 0.0 %
  • 60+: 66.67 %

Common drugs people take besides Azasan *:

  1. Exforge: 2 people, 66.67%
  2. Protonix: 1 person, 33.33%
  3. Myfortic: 1 person, 33.33%
  4. Lialda: 1 person, 33.33%
  5. Humira: 1 person, 33.33%
  6. Glucophage Xr: 1 person, 33.33%
  7. Cellcept: 1 person, 33.33%
  8. Cardura: 1 person, 33.33%
  9. Bentyl: 1 person, 33.33%
  10. Bactrim: 1 person, 33.33%

Common side effects people have besides Haemoglobin decreased *:

  1. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 1 person, 33.33%
  2. Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin): 1 person, 33.33%
  3. Lower Gastrointestinal Haemorrhage (bleeding in the large intestine, rectum, or anus is called lower gi bleeding): 1 person, 33.33%
  4. Injection Site Pain: 1 person, 33.33%
  5. Injection Site Mass: 1 person, 33.33%
  6. Gastric Ulcer (stomach ulcer): 1 person, 33.33%
  7. Blood Creatinine Increased: 1 person, 33.33%

Common conditions people have *:

  1. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 2 people, 66.67%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 33.33%
  3. Gastric Disorder (disease of stomach): 1 person, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take Azasan and have Haemoglobin decreased?

Check whether Haemoglobin decreased is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

How severe was Haemoglobin decreased and when was it recovered:

Expand to all the drugs that have ingredients of azathioprine:

Alternative drugs to, pros and cons of Azasan:

Haemoglobin decreased treatments and more:

COVID vaccines that are related to Haemoglobin decreased:

Common drugs associated with Haemoglobin decreased:

All the drugs that are associated with Haemoglobin decreased:

Common conditions associated with Haemoglobin decreased:

All the conditions that are associated with Haemoglobin decreased:

How the study uses the data?

The study uses data from the FDA. It is based on azathioprine (the active ingredients of Azasan) and Azasan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: